Search Results 81-90 of 16809 for Fibronolytic

  1. Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer - Mayo Clinic

    About this study. The purpose of these phase I/II trial studies is to analyze the side effects and best dose of liposomal irinotecan and rucaparib when ...

  2. Essential Thrombocythemia Clinical Trials - Mayo Clinic Research

    PRM-151 is an investigational drug that is being developed for possible use in the treatment of myelofibrosis (MF), a disease in which the bone marrow, which is ...

  3. Liver fibrosis - Doctors and departments - Mayo Clinic

    Mayo Clinic researchers are committed to improving the understanding, diagnosis and management of liver fibrosis. Mayo researchers were among the first to ...

  4. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  5. A Study Using Momelotinib in Transfusion-Dependent Adults with Primary Myelofibrosis, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis - Mayo Clinic

    A Study Using Momelotinib in Transfusion-Dependent Adults with Primary Myelofibrosis, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis.

  6. Patient-Reported Outcome Questionnaire for Use Among Patients with Myelofibrosis After First Line Treatment Failure - Mayo Clinic

    About this study. The primary goal of this study is to inform and substantiate a measurement strategy and its regulatory documentation pursuant to United ...

  7. A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Patients With Kidney Transplant - Mayo Clinic

    Have had any change in androgen therapy (eg, danazol, oxandrolone, stanozolol, testosterone), tranexamic acid, epsilon-aminocaproic acid, or other fibrinolytics ...

  8. A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    These patients are at high risk for progression of kidney disease, which can result in end-stage renal failure. Participation eligibility. Participant ...

  9. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

    The purpose of this study is to evaluate the safety of alisertib and its effect, bad and/or good, on acute megakaryoblastic leukemia (AMKL) or myelofibrosis (MF) ...

  10. A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases - Mayo Clinic

    The purpose of this study is to investigate the effect of nerandomilast on the extent of pulmonary involvement from baseline to Week 26 as assessed with ...